Revelation Biosciences, Inc.
REVB
$1.13
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.90% | -15.80% | 145.63% | 39.66% | -43.00% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 73.73% | -56.98% | -33.39% | -16.70% | 234.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 31.40% | -15.75% | 139.41% | 36.46% | -40.18% |
|
|
|||||
| Total Current Assets | 31.40% | -15.75% | 139.41% | 36.46% | -40.18% |
| Net Property, Plant & Equipment | 9.04% | 2,997.91% | -32.10% | -16.98% | -24.69% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -- | -- | -- | -- |
| Total Assets | 29.88% | -9.90% | 138.30% | 35.89% | -40.04% |
|
|
|||||
| Total Accounts Payable | 43.41% | -44.20% | 24.86% | 32.60% | -20.23% |
| Total Accrued Expenses | -66.51% | 70.56% | 10.79% | 59.53% | -58.97% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 425.65% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -75.00% | 0.00% | -- |
| Total Other Current Liabilities | -- | -- | -75.00% | 0.00% | -- |
| Total Current Liabilities | -29.08% | 7.75% | 18.17% | 44.04% | -43.07% |
|
|
|||||
| Total Current Liabilities | -29.08% | 7.75% | 18.17% | 44.04% | -43.07% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.83% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -24.49% | 46.77% | 18.17% | 44.04% | -43.07% |
|
|
|||||
| Common Stock & APIC | 12.25% | 0.64% | 18.60% | 7.46% | 0.49% |
| Retained Earnings | -6.09% | -5.35% | -4.24% | -5.74% | -5.06% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 46.59% | -19.46% | 187.57% | 32.80% | -38.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 46.59% | -19.46% | 187.57% | 32.80% | -38.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 46.59% | -19.46% | 187.57% | 32.80% | -38.82% |
|
|
|||||